4.7 Article

Autologous olfactory mucosa mesenchymal stem cells treatment improves the neural network in chronic refractory epilepsy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Transplantation of Nasal Olfactory Mucosa Mesenchymal Stem Cells Benefits Alzheimer's Disease

Chun-Gu Hong et al.

Summary: Alzheimer's disease (AD) is a common neurodegenerative disease that is currently incurable. Transplantation of olfactory mucosa mesenchymal stem cells (OM-MSCs) can alleviate symptoms of AD, promote amyloid-beta clearance, and improve cognitive learning and locomotive behavior.

MOLECULAR NEUROBIOLOGY (2022)

Article Critical Care Medicine

Utx Regulates the NF-κB Signaling Pathway of Natural Stem Cells to Modulate Macrophage Migration during Spinal Cord Injury

Miao Li et al.

Summary: The conditional knockout of UTX on neural stem cells can significantly reduce macrophage assembly and scar hyperplasia, leading to improved neurological function after spinal cord injury (SCI). Furthermore, UTX in NSCs was found to alter macrophage migration, contributing to enhanced recovery of neurological function post-SCI.

JOURNAL OF NEUROTRAUMA (2021)

Article Biotechnology & Applied Microbiology

Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612

Lite Ge et al.

Summary: The study revealed that EVs from hypoxic OM-MSCs can enhance angiogenesis through the miR-612-TP53-HIF-1α-VEGF axis, suggesting a promising therapeutic strategy for ischemic diseases.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Immunology

Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke

Ligen Shi et al.

Summary: The study found that after experimental stroke, Treg cells infiltrate the brain in mice and promote white matter repair and functional recovery. Treg cells enhance microglial reparative activity, promoting oligodendrogenesis and white matter repair. Increasing Treg cell numbers can improve white matter integrity and rescue neurological functions in the long term.

IMMUNITY (2021)

Article Clinical Neurology

Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients

Fedor Hlebokazov et al.

Summary: Autologous mesenchymal stem cell therapy has been found to be safe and effective in drug-resistant epilepsy patients, improving symptoms such as anxiety and depression, with enhanced benefits when combined with levetiracetam. Repeated administration of MSCs has shown additional clinical benefits in reducing seizure frequency and epileptiform EEG activity.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Cell & Tissue Engineering

Hypoxic preconditioning rejuvenates mesenchymal stem cells and enhances neuroprotection following intracerebral hemorrhage via the miR-326-mediated autophagy

Jianyang Liu et al.

Summary: The study demonstrates that hypoxic preconditioning delays OM-MSC senescence and enhances the therapeutic efficacy of OM-MSCs in ICH by upregulating the miR-326/PTBP1/PI3K-mediated autophagy pathway.

STEM CELL RESEARCH & THERAPY (2021)

Review Clinical Neurology

Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates

Susan L. Lindsay et al.

NATURE REVIEWS NEUROLOGY (2020)

Review Clinical Neurology

Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus

Ravindra Arya et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Article Clinical Neurology

Deep brain stimulation for seizure control in drug-resistant epilepsy

Neil Klinger et al.

NEUROSURGICAL FOCUS (2018)

Review Cell & Tissue Engineering

The olfactory mucosa: a potential source of stem cells for hearing regeneration

Emily Young et al.

REGENERATIVE MEDICINE (2018)

Article Medicine, Research & Experimental

Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: An open label study

Fedor Hlebokazov et al.

ADVANCES IN MEDICAL SCIENCES (2017)

Article Cell & Tissue Engineering

Secretome of Olfactory Mucosa Mesenchymal Stem Cell, a Multiple Potential Stem Cell

Lite Ge et al.

STEM CELLS INTERNATIONAL (2016)

Article Biotechnology & Applied Microbiology

Safety and seizure control in patients with mesial temporal lobe epilepsy treated with regional superselective intra-arterial injection of autologous bone marrow mononuclear cells

Jaderson C. DaCosta et al.

Journal of Tissue Engineering and Regenerative Medicine (2016)

Review Neurosciences

Pathway-driven discovery of epilepsy genes

Jeffrey Noebels

NATURE NEUROSCIENCE (2015)

Article Neurosciences

Olfactory mucosa: a rich source of cell therapy for central nervous system repair

Da Duan et al.

REVIEWS IN THE NEUROSCIENCES (2015)

Review Biochemistry & Molecular Biology

The current landscape of adipose-derived stem cells in clinical applications

Ming Hui Lim et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2014)

Article Clinical Neurology

Gene therapy in epilepsy-is it time for clinical trials?

Dimitri M. Kullmann et al.

NATURE REVIEWS NEUROLOGY (2014)

Review Neurosciences

Stem cells as a potential therapy for epilepsy

Steven N. Roper et al.

EXPERIMENTAL NEUROLOGY (2013)

Article Otorhinolaryngology

Adult human nasal mesenchymal stem cells have an unexpected broad anatomic distribution

Bradley J. Goldstein et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2013)

Article Medicine, Research & Experimental

Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions

Emmanuel Nivet et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Clinical Neurology

Mechanisms of epileptogenesis and potential treatment targets

Asla Pitkanen et al.

LANCET NEUROLOGY (2011)

Article Behavioral Sciences

Effects of scopolamine and L-NAME on rats' performance in the object location test

Nikolaos Pitsikas

BEHAVIOURAL BRAIN RESEARCH (2007)